GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » EPIRUS Biopharmaceuticals Inc (OTCPK:EPRSQ) » Definitions » 50-Day SMA

EPIRUS Biopharmaceuticals (EPIRUS Biopharmaceuticals) 50-Day SMA : $0.00 (As of May. 28, 2024)


View and export this data going back to 2005. Start your Free Trial

What is EPIRUS Biopharmaceuticals 50-Day SMA?

Moving averages are one of the core indicators in technical analysis. A Simple Moving Average (SMA) is simply the arithmetic average of stock price over a period. It is calculated by adding a selected range of prices, usually closing prices, and then dividing that figure by the number of time periods in that range.

The 50-Day SMA calculates the average price over 50 days. And the 20-Day SMA and 200-Day SMA calculates the average price over 20 days and 200 days separately.

As of today (2024-05-28), EPIRUS Biopharmaceuticals's 50-Day SMA is $0.00. It's 20-Day SMA is $0.00 and 200-Day SMA is $0.00.


Competitive Comparison of EPIRUS Biopharmaceuticals's 50-Day SMA

For the Biotechnology subindustry, EPIRUS Biopharmaceuticals's 50-Day SMA, along with its competitors' market caps and 50-Day SMA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


EPIRUS Biopharmaceuticals's 50-Day SMA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, EPIRUS Biopharmaceuticals's 50-Day SMA distribution charts can be found below:

* The bar in red indicates where EPIRUS Biopharmaceuticals's 50-Day SMA falls into.



EPIRUS Biopharmaceuticals  (OTCPK:EPRSQ) 50-Day SMA Calculation

The formula for calculating SMA is:

SMA=( P1 + P2 + ... + Pn ) / n

where:
Pn is the price of the stock at period n.
n is the total number of periods.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


EPIRUS Biopharmaceuticals  (OTCPK:EPRSQ) 50-Day SMA Explanation

Simple Moving Average (SMA) is the arithmetic average of stock price over a period. The 20-Day SMA calculates the average price over 20 days. And the 50-Day SMA and 200-Day SMA calculates the average price over 50 days and 200 days separately. SMAs are often used to determine the price trend direction. A 200-Day SMA is usually a proxy for the long-term trend, while shorter periods indicate short-term trend.

SMA are commonly compared with stock price or different period SMAs to indicate a trading signal. Generally speaking, if the price goes above the SMA, or a short-term SMA crosses above a long-term SMA, an uptrend is expected, investors may want to go long or cover short. Conversely, if the price goes below the SMA, or the short-term SMA crosses below a long-term SMA, a downtrend is expected, investors may want to go short or exit long.

Two popular trading patterns that use SMA include the death cross and a golden cross. A death cross occurs when the 50-day SMA crosses below the 200-day SMA. This is considered a bearish signal, that further losses are in store. The golden cross is a bullish signal which occurs when a short-term SMA crosses above a long-term SMA.


EPIRUS Biopharmaceuticals 50-Day SMA Related Terms

Thank you for viewing the detailed overview of EPIRUS Biopharmaceuticals's 50-Day SMA provided by GuruFocus.com. Please click on the following links to see related term pages.


EPIRUS Biopharmaceuticals (EPIRUS Biopharmaceuticals) Business Description

Traded in Other Exchanges
N/A
Address
699 Boylston Street, Eighth Floor, Boston, MA, USA, 02116
EPIRUS Biopharmaceuticals Inc is a global biopharmaceutical company focused on building biosimilar business targeting rare diseases by improving patient access through cost-effective medicines. The product candidates of the company are BOW080 for the potential treatment of ultra-rare blood disorders and BOW070 for the potential treatment of an uncommon lymphoproliferative disorder known as Castleman's disease. The group generally operates through the United States.
Executives
Vincent Aurentz officer: Chief Business Officer C/O ARENA PHARMACEUTICALS, INC., 6154 NANCY RIDGE DRIVE, SAN DIEGO CA 92121
Thomas A. Shea officer: Chief Financial Officer C/O EPIRUS BIOPHARMACEUTICALS, INC., 699 BOYLSTON STREET 8TH FLOOR, BOSTON MA 02116
Amit Munshi director, officer: Chief Executive Officer C/O EPIRUS BIOPHARMACEUTICALS, INC., 699 BOYLSTON STREET, 8TH FLOOR, BOSTON MA 02116
Scott M Rocklage director, 10 percent owner C/O 5AM VENTURES, 501 2ND STREET, SUITE 350, SAN FRANCISCO CA 94107
Julie Mchugh director C/O IRONWOOD PHARMACEUTICALS, INC., 100 SUMMER STREET, SUITE 2300, BOSTON MA 02110
Mark Corrigan director
Geoffrey M Duyk director 301 COMMERCE STREET, SUITE 3300, FORT WORTH TX 76102
J Kevin Buchi director 41 MOORES ROAD, FRAZER PA 19355
Montreux Equity Partners Iv Lp 10 percent owner ONE FERRY BUILDING,, SUITE 255, SAN FRANCISCO CA 94111
5am Ventures Iii, L.p. 10 percent owner 2200 SAND HILL ROAD, SUITE 110, MENLO PARK CA 94025
5am Co-investors Iii, L.p. 10 percent owner 2200 SAND HILL ROAD, SUITE 110, MENLO PARK CA 94025
Andrew J. Schwab 10 percent owner C/O 5AM VENTURES, 501 2ND STREET, SUITE 350, SAN FRANCISCO CA 94107
John D Diekman 10 percent owner C/O 5 AM VENTURES, 501 2ND STREET, SUITE 350, SAN FRANCISCO CA 94107
5am Partners Iii, Llc 10 percent owner 2200 SAND HILL ROAD STE 110, MENLO PARK CA 94025
David Bonderman 10 percent owner 301 COMMERCE STREET, SUITE 3300, FORT WORTH TX 76102

EPIRUS Biopharmaceuticals (EPIRUS Biopharmaceuticals) Headlines

From GuruFocus

CEO of Epirus Biopharmaceuticals Buys 10,000 Shares

By Jennifer Chiou Jennifer Chiou 09-23-2015